CTAC NV (CTAC.AS) Fundamental Analysis & Valuation

AMS:CTAC • NL0000345577

Current stock price

2.93 EUR
+0.11 (+3.9%)
Last:

This CTAC.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CTAC.AS Profitability Analysis

1.1 Basic Checks

  • In the past year CTAC was profitable.
  • In the past year CTAC had a positive cash flow from operations.
  • Each year in the past 5 years CTAC has been profitable.
  • In the past 5 years CTAC always reported a positive cash flow from operatings.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.74%, CTAC is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • CTAC has a Return On Equity of 16.41%. This is in the better half of the industry: CTAC outperforms 76.00% of its industry peers.
  • With a decent Return On Invested Capital value of 9.71%, CTAC is doing good in the industry, outperforming 62.67% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CTAC is significantly below the industry average of 27.67%.
Industry RankSector Rank
ROA 7.74%
ROE 16.41%
ROIC 9.71%
ROA(3y)3.98%
ROA(5y)4.84%
ROE(3y)8.98%
ROE(5y)11.99%
ROIC(3y)10.26%
ROIC(5y)11.02%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CTAC's Profit Margin of 2.86% is in line compared to the rest of the industry. CTAC outperforms 48.00% of its industry peers.
  • CTAC's Profit Margin has declined in the last couple of years.
  • CTAC's Operating Margin of 2.63% is on the low side compared to the rest of the industry. CTAC is outperformed by 73.33% of its industry peers.
  • CTAC's Operating Margin has declined in the last couple of years.
  • CTAC has a worse Gross Margin (35.24%) than 68.00% of its industry peers.
  • CTAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.63%
PM (TTM) 2.86%
GM 35.24%
OM growth 3Y-12.38%
OM growth 5Y-6.66%
PM growth 3Y-10.68%
PM growth 5Y-3.79%
GM growth 3Y-5.01%
GM growth 5Y-4.72%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CTAC.AS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CTAC is creating some value.
  • Compared to 1 year ago, CTAC has about the same amount of shares outstanding.
  • CTAC has more shares outstanding than it did 5 years ago.
  • CTAC has a better debt/assets ratio than last year.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

  • CTAC has an Altman-Z score of 4.03. This indicates that CTAC is financially healthy and has little risk of bankruptcy at the moment.
  • CTAC has a Altman-Z score of 4.03. This is amongst the best in the industry. CTAC outperforms 82.67% of its industry peers.
  • CTAC has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • CTAC has a better Debt to Equity ratio (0.16) than 72.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 4.03
ROIC/WACC1.44
WACC6.74%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M 30M

2.3 Liquidity

  • CTAC has a Current Ratio of 1.10. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CTAC (1.10) is worse than 64.00% of its industry peers.
  • CTAC has a Quick Ratio of 1.10. This is a normal value and indicates that CTAC is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.10, CTAC is not doing good in the industry: 61.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CTAC.AS Growth Analysis

3.1 Past

  • CTAC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.93%.
  • Measured over the past 5 years, CTAC shows a small growth in Earnings Per Share. The EPS has been growing by 2.95% on average per year.
  • The Revenue has been growing slightly by 1.11% in the past year.
  • Measured over the past years, CTAC shows a small growth in Revenue. The Revenue has been growing by 7.56% on average per year.
EPS 1Y (TTM)-7.93%
EPS 3Y-9.43%
EPS 5Y2.95%
EPS Q2Q%-18.74%
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.23%
Revenue growth 5Y7.56%
Sales Q2Q%0.78%

3.2 Future

  • Based on estimates for the next years, CTAC will show a decrease in Earnings Per Share. The EPS will decrease by 0.00% on average per year.
  • The Revenue is expected to grow by 7.04% on average over the next years.
EPS Next Y16.07%
EPS Next 2Y7.74%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue Next Year4.33%
Revenue Next 2Y4.24%
Revenue Next 3Y2.31%
Revenue Next 5Y7.04%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

6

4. CTAC.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.72, the valuation of CTAC can be described as very reasonable.
  • Based on the Price/Earnings ratio, CTAC is valued cheaper than 82.67% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.87. CTAC is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 8.84, the valuation of CTAC can be described as very reasonable.
  • 80.00% of the companies in the same industry are more expensive than CTAC, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 38.51, CTAC is valued rather cheaply.
Industry RankSector Rank
PE 11.72
Fwd PE 8.84
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CTAC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTAC is cheaper than 86.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.34
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.73
PEG (5Y)3.98
EPS Next 2Y7.74%
EPS Next 3Y0%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. CTAC.AS Dividend Analysis

5.1 Amount

  • CTAC has a Yearly Dividend Yield of 3.87%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.80, CTAC pays a bit more dividend than its industry peers.
  • CTAC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.87%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

  • 28.82% of the earnings are spent on dividend by CTAC. This is a low number and sustainable payout ratio.
DP28.82%
EPS Next 2Y7.74%
EPS Next 3Y0%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CTAC.AS Fundamentals: All Metrics, Ratios and Statistics

CTAC NV

AMS:CTAC (4/16/2026, 7:00:00 PM)

2.93

+0.11 (+3.9%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners2.89%
Inst Owner ChangeN/A
Ins Owners22.2%
Ins Owner ChangeN/A
Market Cap41.46M
Revenue(TTM)188.71M
Net Income(TTM)5.40M
Analysts80
Price Target2.87 (-2.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.87%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP28.82%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.36%
Valuation
Industry RankSector Rank
PE 11.72
Fwd PE 8.84
P/S 0.22
P/FCF N/A
P/OCF 65.91
P/B 1.26
P/tB 5.81
EV/EBITDA 4.34
EPS(TTM)0.25
EY8.53%
EPS(NY)0.33
Fwd EY11.31%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.04
OCFY1.52%
SpS13.34
BVpS2.33
TBVpS0.5
PEG (NY)0.73
PEG (5Y)3.98
Graham Number3.61688 (23.44%)
Profitability
Industry RankSector Rank
ROA 7.74%
ROE 16.41%
ROCE 12.62%
ROIC 9.71%
ROICexc 11%
ROICexgc 42.74%
OM 2.63%
PM (TTM) 2.86%
GM 35.24%
FCFM N/A
ROA(3y)3.98%
ROA(5y)4.84%
ROE(3y)8.98%
ROE(5y)11.99%
ROIC(3y)10.26%
ROIC(5y)11.02%
ROICexc(3y)12.83%
ROICexc(5y)13.89%
ROICexgc(3y)121.73%
ROICexgc(5y)145.43%
ROCE(3y)13.49%
ROCE(5y)14.56%
ROICexgc growth 3Y-18.29%
ROICexgc growth 5Y-22.64%
ROICexc growth 3Y-9.77%
ROICexc growth 5Y-4.88%
OM growth 3Y-12.38%
OM growth 5Y-6.66%
PM growth 3Y-10.68%
PM growth 5Y-3.79%
GM growth 3Y-5.01%
GM growth 5Y-4.72%
F-Score6
Asset Turnover2.71
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 0.52
Cap/Depr 28.44%
Cap/Sales 0.81%
Interest Coverage 13.63
Cash Conversion 6.08%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 4.03
F-Score6
WACC6.74%
ROIC/WACC1.44
Cap/Depr(3y)42.32%
Cap/Depr(5y)33.13%
Cap/Sales(3y)1.77%
Cap/Sales(5y)1.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.93%
EPS 3Y-9.43%
EPS 5Y2.95%
EPS Q2Q%-18.74%
EPS Next Y16.07%
EPS Next 2Y7.74%
EPS Next 3Y0%
EPS Next 5YN/A
Revenue 1Y (TTM)1.11%
Revenue growth 3Y2.23%
Revenue growth 5Y7.56%
Sales Q2Q%0.78%
Revenue Next Year4.33%
Revenue Next 2Y4.24%
Revenue Next 3Y2.31%
Revenue Next 5Y7.04%
EBIT growth 1Y-10.74%
EBIT growth 3Y-10.42%
EBIT growth 5Y0.4%
EBIT Next Year118.18%
EBIT Next 3Y29.7%
EBIT Next 5YN/A
FCF growth 1Y-112.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.88%
OCF growth 3Y-52.08%
OCF growth 5Y-47.08%

CTAC NV / CTAC.AS Fundamental Analysis FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 4 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 6 / 10 to CTAC NV (CTAC.AS). This can be considered as Fairly Valued.


What is the profitability of CTAC stock?

CTAC NV (CTAC.AS) has a profitability rating of 4 / 10.


How financially healthy is CTAC NV?

The financial health rating of CTAC NV (CTAC.AS) is 4 / 10.


Can you provide the expected EPS growth for CTAC stock?

The Earnings per Share (EPS) of CTAC NV (CTAC.AS) is expected to grow by 16.07% in the next year.